에서 실시간으로 운영 중이에요!
자세히 알아보기
Anebulo Pharmaceuticals
ANEB
ANEB
상장 폐지됨
ANEB 종목은 2026년 2월 27일에 상장 폐지됐어요.
소개: Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
직원 수: 3
뉴스
긍정적
중립
부정적
투자 심리
3개월
긍정적
0%
중립
0%
부정적
0%
Lightweight Charts™를 사용해 가격 차트를 구현했어요.